Source Reference: Taubmann J, et al "Long term safety and efficacy of CAR-T cell treatment in refractory systemic lupus erythematosus - data from the first seven patients" EULAR 2023; Abstract OP0141.

The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. For the 2023 ...

Aurinia welcomes the 2023 updated recommendations from EULAR for the management of systemic lupus erythematosus based on emerging new evidence, including a new treatment paradigm for lupus nephritis.

Boumpas D. EULAR-Recommendations on the management of lupus. Presented at: EULAR 2023 Congress; May 31 to June 3, 2023, Milan, Italy. Disclosures: Boumpas reported no relevant financial disclosures.

Elsewhere at EULAR 2024, positive results of another phase 2 study involving a drug with an entirely different mechanism of action, KPG-818, were reported in a poster presentation.

Key takeaways: EULAR has released new recommendations for non-pharmacologic management of lupus and systemic sclerosis. The new guideline includes recommendations encouraging physical exercise for ...

HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health Hospital for Special Surgery (HSS) presented a ...

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) -- Eli Lilly and Company presented new data for OLUMIANT® (baricitinib) at the virtual European Congress of Rheumatology (EULAR 2020).

The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. For the 2023 ...

BARCELONA, Spain-- (BUSINESS WIRE)--Jun 14, 2025--HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health ...